Regulators participating in the ACCESS Consortium, an international work-sharing scheme to accelerate drug approvals, have introduced joint pipeline meetings for drug and biotech companies to confidentially discuss potential new submissions under the initiative and other topics.
The ACCESS Consortium comprises regulators from Australia, Canada, Singapore, Switzerland and the UK, which use a network of bilateral confidentiality agreements
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?